-
San Diego Biotech Company Admits Fraudulent Billing, Agrees to Pay $49 Million
A San Diego-based biotech company agreed Friday to pay $49 million to settle allegations it fraudulently billed federal health insurance programs and offered kickbacks to physicians and patients to use its services.